Bavarian Nordic A/S  

(Public, CPH:BAVA)   Watch this stock  
Find more results for BAVA
+3.50 (1.10%)
Jul 31 - Close
CPH real-time data - Disclaimer
Currency in DKK
Range 315.50 - 325.50
52 week 106.50 - 393.00
Open 320.00
Vol / Avg. 114,717.00/132,675.00
Mkt cap 8.93B
P/E 132.57
Div/yield     -
EPS 2.42
Shares 27.81M
Beta     -
Inst. own     -
Jun 15, 2015
Bavarian Nordic A/S at Citi European Healthcare Conference
Jun 1, 2015
Bavarian Nordic A/S at Jefferies Global Healthcare Conference

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 19.34% 2.13%
Operating margin -17.12% 1.37%
EBITD margin - 5.06%
Return on average assets 8.37% 1.55%
Return on average equity 14.45% 2.33%
Employees 421 -
CDP Score - -


Hejreskovvej 10A, Munkegarde

Website links


Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The Company is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

Officers and directors

Gerard W. M. van Odijk M.D. Independent Chairman of the Board
Age: 58
Paul Chaplin Ph.D. President, Chief Executive Officer
Age: 48
Anders Gersel Pedersen M.D. Independent Deputy Chairman of the Board
Age: 64
Ole Larsen Chief Financial Officer, Executive Vice President
Age: 50
James B. Breitmeyer Executive Vice President and Chief Development Officer
Age: 62
Claus Braestrup Ph.D. Independent Director
Age: 70
Erik Gregers Hansen Independent Director
Age: 63
Peter Kurstein Independent Director
Age: 59